• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻二酚可降低非肥胖糖尿病小鼠的糖尿病发病率。

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.

作者信息

Weiss L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavin S, Gallily R

机构信息

Hadassah University Hospital, Department of Bone Marrow Transplantation & Cancer Immunotherapy, POB 12000, Jerusalem, 91120, Israel.

出版信息

Autoimmunity. 2006 Mar;39(2):143-51. doi: 10.1080/08916930500356674.

DOI:10.1080/08916930500356674
PMID:16698671
Abstract

Cannabidinoids are components of the Cannabis sativa (marijuana) plant that have been shown capable of suppressing inflammation and various aspects of cell-mediated immunity. Cannabidiol (CBD), a non-psychoactive cannabidinoid has been previously shown by us to suppress cell-mediated autoimmune joint destruction in an animal model of rheumatoid arthritis. We now report that CBD treatment significantly reduces the incidence of diabetes in NOD mice from an incidence of 86% in non-treated control mice to an incidence of 30% in CBD-treated mice. CBD treatment also resulted in the significant reduction of plasma levels of the pro-inflammatory cytokines, IFN-gamma and TNF-alpha. Th1-associated cytokine production of in vitro activated T-cells and peritoneal macrophages was also significantly reduced in CBD-treated mice, whereas production of the Th2-associated cytokines, IL-4 and IL-10, was increased when compared to untreated control mice. Histological examination of the pancreatic islets of CBD-treated mice revealed significantly reduced insulitis. Our results indicate that CBD can inhibit and delay destructive insulitis and inflammatory Th1-associated cytokine production in NOD mice resulting in a decreased incidence of diabetes possibly through an immunomodulatory mechanism shifting the immune response from Th1 to Th2 dominance.

摘要

大麻素是大麻植物的成分,已被证明能够抑制炎症和细胞介导免疫的各个方面。大麻二酚(CBD)是一种无精神活性的大麻素,我们之前已证明它能在类风湿性关节炎动物模型中抑制细胞介导的自身免疫性关节破坏。我们现在报告,CBD治疗可显著降低NOD小鼠的糖尿病发病率,未治疗的对照小鼠发病率为86%,而接受CBD治疗的小鼠发病率为30%。CBD治疗还导致促炎细胞因子IFN-γ和TNF-α的血浆水平显著降低。与未治疗的对照小鼠相比,接受CBD治疗的小鼠体外活化T细胞和腹腔巨噬细胞的Th1相关细胞因子产生也显著降低,而Th2相关细胞因子IL-4和IL-10的产生增加。对接受CBD治疗的小鼠胰岛进行组织学检查发现胰岛炎显著减轻。我们的结果表明,CBD可以抑制和延缓NOD小鼠的破坏性胰岛炎和炎症性Th1相关细胞因子产生,从而降低糖尿病发病率,这可能是通过一种免疫调节机制将免疫反应从Th1主导转变为Th2主导实现的。

相似文献

1
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.大麻二酚可降低非肥胖糖尿病小鼠的糖尿病发病率。
Autoimmunity. 2006 Mar;39(2):143-51. doi: 10.1080/08916930500356674.
2
IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.白细胞介素-18通过对依赖Th1的破坏性胰岛炎进行反向调节,抑制非肥胖糖尿病小鼠的糖尿病发展。
J Immunol. 1999 Aug 1;163(3):1230-6.
3
A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice.一种小鼠白细胞介素-4-Ig融合蛋白可调节非肥胖糖尿病(NOD)小鼠胰腺中Th1和Th2特异性细胞因子的表达。
Horm Metab Res. 2002 Oct;34(10):561-9. doi: 10.1055/s-2002-35417.
4
Demonstration of a TH1 cytokine profile in the late phase of NOD insulitis.在非肥胖糖尿病(NOD)胰岛炎晚期TH1细胞因子谱的证实。
Cytokine. 1995 Nov;7(8):806-14. doi: 10.1006/cyto.1995.0097.
5
IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.白细胞介素-4通过增强调节性辅助性T细胞2功能,预防非肥胖糖尿病小鼠的胰岛炎和胰岛素依赖型糖尿病。
J Immunol. 1997 Nov 15;159(10):4686-92.
6
Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.用白细胞介素(IL)-12拮抗剂IL-12(p40)2治疗的非肥胖糖尿病(NOD)小鼠中,环磷酰胺诱导的糖尿病发展及胰腺Th1反应性受到抑制。
Diabetologia. 1997 Jun;40(6):641-6. doi: 10.1007/s001250050728.
7
Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.合成糖脂OCH可预防非肥胖糖尿病(NOD)小鼠的胰岛炎和糖尿病。
J Autoimmun. 2004 Dec;23(4):293-300. doi: 10.1016/j.jaut.2004.09.008.
8
[Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].普伐他汀预防糖尿病的作用及其机制:非肥胖糖尿病小鼠实验
Zhonghua Yi Xue Za Zhi. 2008 Feb 26;88(8):568-72.
9
Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.低剂量西罗莫司和他克莫司联合治疗在预防非肥胖糖尿病小鼠的自发性和复发性自身免疫性糖尿病方面具有协同作用。
Diabetologia. 2002 Feb;45(2):224-30. doi: 10.1007/s00125-001-0745-x.
10
Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.T细胞在非肥胖糖尿病(NOD)小鼠模型自身免疫性糖尿病发生发展中的作用。
Bioessays. 1998 Sep;20(9):750-7. doi: 10.1002/(SICI)1521-1878(199809)20:9<750::AID-BIES8>3.0.CO;2-K.

引用本文的文献

1
Cannabidiol as an immune modulator: A comprehensive review.大麻二酚作为一种免疫调节剂:综述
Saudi Pharm J. 2025 May 23;33(3):11. doi: 10.1007/s44446-025-00005-7.
2
Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies.揭示大麻二酚的抗糖尿病潜力:体内临床前研究
Pharmaceuticals (Basel). 2025 Mar 21;18(4):446. doi: 10.3390/ph18040446.
3
Association between cannabis use and physical activity in the United States based on legalization and health status.基于大麻合法化和健康状况的美国大麻使用与身体活动之间的关联。
J Cannabis Res. 2024 Oct 9;6(1):39. doi: 10.1186/s42238-024-00248-6.
4
Unleashing the therapeutic role of cannabidiol in dentistry.释放大麻二酚在牙科中的治疗作用。
J Oral Biol Craniofac Res. 2024 Sep-Oct;14(5):649-654. doi: 10.1016/j.jobcr.2024.09.001. Epub 2024 Sep 7.
5
Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.药物靶向大麻素受体 1 可影响免疫细胞和胰岛之间的串扰,从而减少人类的胰岛炎。
Diabetologia. 2024 Sep;67(9):1877-1896. doi: 10.1007/s00125-024-06193-6. Epub 2024 Jun 12.
6
The Effects of Nicotine and Cannabinoids on Cytokines.尼古丁和大麻素对细胞因子的影响。
Curr Pharm Des. 2024;30(31):2468-2484. doi: 10.2174/0113816128293077240529111824.
7
Cannabidiol alleviates carbon tetrachloride-induced liver fibrosis in mice by regulating NF-κB and PPAR-α pathways.大麻二酚通过调节 NF-κB 和 PPAR-α 通路减轻四氯化碳诱导的小鼠肝纤维化。
Exp Biol Med (Maywood). 2024 Apr 22;249:10141. doi: 10.3389/ebm.2024.10141. eCollection 2024.
8
Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Condition.大麻在管理新冠后患者神经炎症中的可能作用。
Int J Mol Sci. 2024 Mar 29;25(7):3805. doi: 10.3390/ijms25073805.
9
Influence of short-term chronic oral cannabidiol application on muscle recovery and performance after an intensive training protocol - a randomized double-blind crossover study.短期慢性口服大麻二酚对强化训练方案后肌肉恢复和表现的影响 - 一项随机、双盲、交叉研究。
J Int Soc Sports Nutr. 2024 Dec;21(1):2337252. doi: 10.1080/15502783.2024.2337252. Epub 2024 Apr 4.
10
The Role of Cannabidiol in Liver Disease: A Systemic Review.大麻二酚在肝脏疾病中的作用:系统评价。
Int J Mol Sci. 2024 Feb 17;25(4):2370. doi: 10.3390/ijms25042370.